Successful treatment of Sjogren's syndrome with rituximab
- 1 January 2006
- journal article
- Published by Taylor & Francis Ltd in Scandinavian Journal of Rheumatology
- Vol. 35 (4), 323-325
- https://doi.org/10.1080/03009740500484056
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Rituximab treatment in patients with primary Sjögren's syndrome: An open‐label phase II studyArthritis & Rheumatism, 2005
- Anti‐CD20 therapy of treatment‐resistant Wegener's granulomatosis: favourable but temporary responseScandinavian Journal of Rheumatology, 2005
- Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseasesAnnals Of The Rheumatic Diseases, 2005
- Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with Sjogren's syndrome and associated MALT lymphomaAnnals Of The Rheumatic Diseases, 2005
- Biopsy-verified response of severe lupus nephritis to treatment with rituximab (anti-CD20 monoclonal antibody) plus cyclophosphamide after biopsy-documented failure to respond to cyclophosphamide aloneScandinavian Journal of Rheumatology, 2004
- Letter to the EditorLupus, 2004
- Rituximab therapy and autoimmune disorders: Prospects for anti–B cell therapyArthritis & Rheumatism, 2003
- Improvement in Sjögren's syndrome following therapy with rituximab for marginal zone lymphomaArthritis Care & Research, 2003
- Rituximab for the treatment of type II mixed cryoglobulinemiaArthritis & Rheumatism, 2002
- Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European communityArthritis & Rheumatism, 1993